Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Adial Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −10 vs. Q2 2023
- Shares held
- 59.1K
- −34.6K (−36.9%) vs. Q2 2023Converted for a 1-for-25 split
- Total value
- $164.2K
- −$324.0K (−66.4%) vs. Q2 2023
- New holders
- 3
- 1 more added
- Sold out
- 13
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manchester Capital Management LLC | 48,097 | $133.7K | 0.02% | 00.0% | UnchangedConverted for a 1-for-25 split |
| BlackRock Inc. | 7,639 | $21.2K | 0.00% | −136−1.7% | ReducedConverted for a 1-for-25 split |
| Raffa Wealth Management, LLC | 2,093 | $5.82K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Advisor Group Holdings, Inc. | 615 | $1.71K | 0.00% | −347−36.1% | ReducedConverted for a 1-for-25 split |
| UBS Group AG | 546 | $1.52K | 0.00% | +546 | New |
| Abound Wealth Management | 27 | $76 | 0.00% | +27 | New |
| Morgan Stanley | 21 | $58 | 0.00% | −0−1.9% | ReducedConverted for a 1-for-25 split |
| Wells Fargo & Company | 8 | $22 | 0.00% | +1+7.0% | AddedConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 8 | $21 | 0.00% | +8 | New |
| Royal Bank of Canada | 38 | $0 | 0.00% | −1−1.5% | ReducedConverted for a 1-for-25 split |
| Benjamin F. Edwards & Company, Inc. | 40 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −8,134−100.0% | Sold outConverted for a 1-for-25 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −7,211−100.0% | Sold outConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −5,499−100.0% | Sold outConverted for a 1-for-25 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −4,284−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −2,094−100.0% | Sold outConverted for a 1-for-25 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −1,458−100.0% | Sold outConverted for a 1-for-25 split |
| Truist Financial Corp | 0 | $0 | 0.00% | −1,354−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,188−100.0% | Sold outConverted for a 1-for-25 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,059−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −828−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −705−100.0% | Sold outConverted for a 1-for-25 split |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −524−100.0% | Sold outConverted for a 1-for-25 split |
| Creative Planning | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |